WBA Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 1/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$16.50 |
52 Week High | US$31.75 |
52 Week Low | US$16.50 |
Beta | 0.75 |
1 Month Change | -12.90% |
3 Month Change | -21.44% |
1 Year Change | -48.03% |
3 Year Change | -62.13% |
5 Year Change | -65.28% |
Change since IPO | -77.14% |
Recent News & Updates
Recent updates
Shareholder Returns
WBA | AT Consumer Retailing | AT Market | |
---|---|---|---|
7D | -0.1% | 1.3% | 0.7% |
1Y | -48.0% | -5.2% | 2.7% |
Return vs Industry: WBA underperformed the Austrian Consumer Retailing industry which returned -4% over the past year.
Return vs Market: WBA underperformed the Austrian Market which returned 3.7% over the past year.
Price Volatility
WBA volatility | |
---|---|
WBA Average Weekly Movement | 4.4% |
Consumer Retailing Industry Average Movement | 4.7% |
Market Average Movement | 3.4% |
10% most volatile stocks in AT Market | 5.2% |
10% least volatile stocks in AT Market | 1.5% |
Stable Share Price: WBA's share price has been volatile over the past 3 months.
Volatility Over Time: WBA's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
WBA fundamental statistics | |
---|---|
Market cap | €14.32b |
Earnings (TTM) | -€5.63b |
Revenue (TTM) | €134.79b |
0.1x
P/S Ratio-2.5x
P/E RatioIs WBA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WBA income statement (TTM) | |
---|---|
Revenue | US$144.60b |
Cost of Revenue | US$117.72b |
Gross Profit | US$26.88b |
Other Expenses | US$32.91b |
Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.00 |
Gross Margin | 18.59% |
Net Profit Margin | -4.18% |
Debt/Equity Ratio | 61.7% |
How did WBA perform over the long term?
See historical performance and comparison